Fig. 1From: Experience using mTOR inhibitors for subependymal giant cell astrocytoma in tuberous sclerosis complex at a single facilityAt the time of latest follow-up, patients receiving mammalian target of rapamycin inhibitors (mTORi) showed reduced size of the SEGA compared with the wait-and-see policy group (p = 0.012). The number in parentheses after each case shows total follow-up in months. Neuroradiological follow-up was performed every 1–3 yearsBack to article page